Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Antisense Therapeutics

    Client Virtual Booth

    ANTISENSE THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Antisense Therapeutics
    Australia Flag
    Country
    Country
    Australia
    Address
    Address
    6 Wallace Avenue Toorak, Victoria, 3142
    Telephone
    Telephone
    +61 (3) 9827 8999
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.antisense.com.au/
    Linkedin
    Linkedin
    https://au.linkedin.com/company/antisense-therapeutics-ltd.
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    COVID-19 study- Novel blood markers as future diagnostic & therapeutic targets
    COVID-19 study- Novel blood markers as future diagnostic & therapeutic targets

    https://www.globenewswire.com/news-release/2022/08/23/2503212/0/en/Long-COVID-19-study-identifies-novel-blood-markers-as-potential-diagnostic-and-therapeutic-targets.html

    GLOBENEWSWIRE
    23 Aug 2022
    Share Share
    Antisense Tx to present poster at world’s largest NMD conference
    Antisense Tx to present poster at world’s largest NMD conference

    https://www.globenewswire.com/news-release/2022/03/09/2400311/0/en/Antisense-Therapeutics-to-present-poster-at-world-s-largest-NMD-conference.html

    GLOBENEWSWIRE
    09 Mar 2022
    Share Share
    Antisense Therapeutics Announces a Poster Presentation on the MDA
    Antisense Therapeutics Announces a Poster Presentation on the MDA

    https://www.businesswire.com/news/home/20200611005274/en/Antisense-Therapeutics-Announces-Poster-Presentation-Muscular-Dystrophy

    BUSINESSWIRE
    11 Jun 2020
    Share Share
    Antisense ATL1102 Final Phase II DMD Results Meet Primary Endpoint
    Antisense ATL1102 Final Phase II DMD Results Meet Primary Endpoint

    https://www.businesswire.com/news/home/20200521005411/en

    BUSINESSWIRE
    21 May 2020
    Share Share
    Antisense ATL1102 Final Phase II DMD Results Meet Primary Endpoint
    Antisense ATL1102 Final Phase II DMD Results Meet Primary Endpoint

    https://www.marketwatch.com/press-release/antisense-atl1102-final-phase-ii-dmd-results-meet-primary-endpoint-and-exceed-expectations-on-secondary-endpoints-2020-05-21?mod=mw_more_headlines&tesla=y

    MARKETWATCH
    21 May 2020
    Share Share
    Positive results reaffirm plans to advance ATL1102 for DMD to Phase IIb trial
    Positive results reaffirm plans to advance ATL1102 for DMD to Phase IIb trial

    https://www.biospace.com/article/releases/positive-results-reaffirm-plans-to-advance-atl1102-for-dmd-to-phase-iib-trial/?s=62

    BIO SPACE
    17 Dec 2019
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search